 |
인쇄하기
취소
|
Korean drug firm signs record license deal
Korean biopharmaceutical company Medytox said Thursday that it has signed a deal to exclusively license a neurotoxin to Procter & Gamble Pharmaceuticals (P&GP) that could be worth US$$362 million.
Under the deal, Allergan will pay Medytox an upfront payment of US$65 million and Medytox will grant Allergan exclusive rights, worldwide outside of Korea, to develop and, if approved, commercializ...
Under the deal, Allergan will pay Medytox an upfront payment of US$65 million and Medytox will grant Allergan exclusive rights, worldwide outside of Korea, to develop and, if approved, commercializ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.